Medline Transitions to Global ESG Reporting, Launches First Edition

Medline has released its first global Environmental, Social, and Governance (ESG) Report. The 2022 report is the culmination of Medline's shift towards a comprehensive ESG framework—expanding its focus to cover the full scope of the company's global operations across more than 125 countries.

This latest report on Medline’s activities, as related to environmental sustainability, community engagement, and facilitating healthcare access and affordability, represents a significant step in an ongoing commitment towards securing a more sustainable and inclusive future. Medline has been reporting its impact since 2016.

‘We’ve adopted a more holistic view of what it means to be a good corporate citizen worldwide,’ said Jim Boyle, Medline’s Chief Executive Officer-Elect. ‘This report is global in scope and it is the first that aligns our efforts to the Sustainability Accounting Standards Board (SASB) standards.’

Significance and highlights

In recent years, ESG considerations have gained increased importance in the healthcare industry. This happens against the backdrop of challenges within the industry with providing quality care, reducing environmental impact, and addressing health disparities. The ESG principles have, therefore, emerged as a vital framework for driving positive change.

The 2022 ESG report introduces Medline's 17 material ESG priorities under four pillars: climate resilience and environmental action, responsible products, people and communities, and robust governance. Highlights of the report include Medline’s:

• Donation of 643 metric tonnes of product—valued at more than USD $2.7 million—in 2022 to support worldwide medical relief to low-resource regions and those that are disproportionately impacted by natural disasters
• Reprocessing of over 2.3 million medical devices in 2022, diverting 1.1 million pounds of waste from landfills
• Completion of 592 social audits towards ensuring ethical sourcing throughout its supply chain in 2022
• Installation of more than 60,000 solar panels at its facilities and investment milestone of USD $34.4 million in solar energy since 2016.

European support

As a longstanding employer and manufacturer of medical devices in Europe and the European Union, Medline Europe looks forward to furthering this collaborative approach. The transition from regional publications represents an opportunity to reinforce and more efficiently communicate on a shared commitment towards helping to improve healthcare outcome and delivery—as well as its impact on the environment and communities in which Medline operates globally.

‘We are proud to showcase our achievements in key areas, such as renewable energy, diversity, equity and inclusion, and community engagement,’ said Hervé Million, President, Medline Europe. ‘By maintaining transparency while sharing our plans and progress, we hope to inspire others and drive positive change in healthcare and around the world.’

Review the 2022 Medline ESG Report, or learn more about our sustainability efforts.

About Medline Europe

Medline Europe is an international manufacturer and global distributor of medical and surgical devices for use in a range of healthcare institutions along the continuum of care. It also provides the clinical and supply chain resources required for long-term financial viability in delivering high-quality care. With a top-tier market share in more than a dozen major medical product categories, and over 1,000 employees throughout 16 countries, Medline Europe has built a reputation of consistently investing in the needs of its customer base and the healthcare industry at large. Its overall mission is to positively impact the market and industry through innovative, customisable and readily available products, services and solutions. Medline Europe is headquartered in Arnhem, the Netherlands. Learn more about Medline Europe at www.medline.eu.